With SGE able to accurately predict cancer risk (Fig. 3b) and enrichment of LoF BARD1 missense variants in breast cancer cases (Fig. 3d), we provide additional evidence that BRCA1 and BARD1’s role in HDR is required for tumor suppression in humans. The gene discussed is BRCA1; the disease is breast carcinoma.